N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-[(4-methoxyphenyl)diphenylmethyl]-L-cysteine, 97%, 10g

1-Bromo-3-chloro-5-(2-methoxyethoxy)benzene, 95.0%, 5g

2,5-Bis-(Trifluoromethyl)pyrazine, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine, 95.0%, 10g

Allyldiphenylphosphine (stabilized with MEHQ), 95.0%, 10g

3,5-Dichloro-6-hydroxypicolinic acid, 95.0%, 1g

2-Bromo-5-fluorobenzenepropanoic acid, 95.0%, 1g

2-Bromo-4-chloro-3-fluorobenzaldehyde, 95%, 5g

Fmoc-Asp-OMe, 95%, 1g

5-Fluorocytidine>97.0%(T)1g

(3R,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one, 95.0%, 50mg

(2-Bromoethoxy)benzene, 98.0%, 1g

2-Bromo-4'-fluoro-3'-(trifluoromethyl)acetophenone>98.0%(GC)5g